サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：PCR技術の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
市場調査レポート
商品コード
1408046

PCR技術の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Global PCR Technologies Market Assessment, By Product, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 217 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
PCR技術の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年01月15日
発行: Market Xcel - Markets and Data
ページ情報: 英文 217 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のPCR技術の市場規模は、2023年に150億5,000万米ドル、2031年に297億5,000万米ドルに達し、2024年～2031年の予測期間にCAGRで8.89%の成長が見込まれています。市場は、分子生物学、ライフサイエンス、バイオテクノロジーの分野で急速に成長しています。市場は、臨床疾患診断や遺伝学的/分子検査におけるPCRの利用の増加により拡大しています。診断にPCR技術を必要とする肝炎、インフルエンザ、HIV感染症、COVID-19などの感染症の流行は近年増加傾向にあり、世界のPCR技術市場の需要を促進しています。

デジタルPCR（dPCR）やリアルタイムPCR（qPCR）などのPCR技術の進歩は、低い試薬消費、ワークフローの自動化、より高い再現性と精度のような利点を提供し、PCR技術の採用を促し、市場成長をさらに促進しています。新興国における市場浸透の高まりと市場における魅力的な機会は、資金調達と投資の増加につながっています。投資家や市場参入企業の関心が高まるにつれ、需給の両方が大幅に増加しています。さらに、研究開発に対する政府の支援が市場の発展をさらに後押ししています。しかし、PCR装置の高いコスト、PCR技術の技術的限界、プロトコルを行う熟練した専門家の不足は、市場の主な抑制要因です。

感染症と遺伝性疾患の有病率の増加

肝炎、インフルエンザ、HIVのような感染症の有病率の増加は、PCR技術市場の重要な促進要因です。感染症や遺伝性疾患の増加は、これらの疾患の診断やモニタリングにおいて重要な役割を果たすため、PCR技術に対する需要の高まりにつながっています。PCRはウイルス、細菌、真菌を含むさまざまな感染因子の検出に広く使用されており、感染症管理に不可欠なツールとなっています。PCR技術は遺伝性疾患の原因となる遺伝子異常の検出にも使用され、市場の成長をさらに後押ししています。

WHOによると、2022年末時点で約3,900万人がHIVとともに生活しており、その中には0～14歳の約150万人の子供も含まれています。冬季の季節性インフルエンザは、人口の最大20%に感染し、重大な死亡をもたらす可能性があります。WHOのデータによると、季節性インフルエンザに関連した呼吸器疾患により、世界全体で毎年65万人が死亡しています。

臨床診断と遺伝学的/分子検査における応用の拡大

PCR技術は臨床診断の分野でいくつかの実用的な用途があり、近年、研究開発の増加に伴い、PCR応用の著しい拡大が見られています。PCR技術はCOVID-19の診断に広く利用されており、市場の需要を促進しています。PCR技術の注目すべき用途には、広域病原体検出、新たな感染症の評価と監視、生物学的脅威の早期検出、抗菌剤耐性の分析があります。市場企業は、PCR技術の新用途に向けた革新的な製品を打ち出しています。

試薬・消耗品セグメントが市場を独占する見込み

試薬・消耗品セグメントは、予測期間に急成長が見込まれます。PCR検査に使用される機器は1回限りの投資であるのに対し、試薬・消耗品は繰り返し消費され購入されるため、主要な収益の促進要因となります。プライマー、ポリメラーゼ、ヌクレオチド、反応バッファーのような試薬や、ウェルプレートやピペットチップのような消耗品は、各PCRプロセスで完全に消費され、次の検査のために再充填する必要があるため、市場で経常的な収益を引き込んでいます。

北米がPCR技術市場をリードする見込み

北米が世界のPCR市場を独占しており、米国とカナダが最大の市場シェアを占めています。この地域の優位性は、広範な研究インフラや、新治療法の承認を迅速にする確立された規制枠組みなどの要因によるものです。この地域の主要な製薬企業やバイオテクノロジー企業のプレゼンスが、PCR技術の開発と採用を促進しています。さらに、北米はPCRの研究開発に多額の投資を誘致し、最先端の施設の設立と先進技術へのアクセスを可能にしています。

当レポートでは、世界のPCR技術市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のPCR技術市場の見通し（2017年～2031年）

  • 市場規模と予測
    • 金額
    • 数量
  • 製品別
    • 器具
    • 試薬
    • 消耗品
    • ソフトウェア、サービス
    • その他
  • 技術別
    • 従来式PCR
    • qPCR（リアルタイムPCR）
    • dPCR（デジタルPCR）
    • その他のPCR技術
  • 用途別
    • 研究用途
    • 診断用途
    • その他
  • エンドユーザー別
    • 病院
    • 診断センター
    • 製薬企業、バイオテクノロジー企業
    • 臨床研究機関
    • 学術研究所
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 市場シェア：企業別（2023年）

第5章 世界のPCR技術市場の見通し：地域別（2017年～2031年）

  • 北米
    • 市場規模と予測
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング（2023年）

  • 治療別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析 - 数量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

  • 臨床試験
  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第10章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析（2023年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場参入企業5社）
  • 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Promega Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN
  • QuantuMDx Group Ltd
  • Eppendorf

第14章 戦略的推奨事項

第15章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 4. Global PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 6. Global PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global PCR Technologies Market Share (%), By Region, 2017-2031F
  • Figure 8. North America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 10. North America PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 11. North America PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 13. North America PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 15. United States PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 17. United States PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 18. United States PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 20. United States PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 23. Canada PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 29. Mexico PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 35. Europe PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 42. Germany PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 46. France PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 48. France PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 49. France PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 50. France PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 51. France PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 54. Italy PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 60. United Kingdom PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 66. Russia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 72. Netherlands PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Spain PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 84. Turkey PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Poland PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 96. South America PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 97. South America PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 99. South America PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 103. Brazil PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 109. Argentina PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 115. Asia-Pacific PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 120. India PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 122. India PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 123. India PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 124. India PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 125. India PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 126. China PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 128. China PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 129. China PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 130. China PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 131. China PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 134. Japan PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 140. Australia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 146. Vietnam PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 152. South Korea PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 158. Indonesia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 164. Philippines PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 170. Middle East & Africa PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa PCR Technologies Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 177. Saudi Arabia PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 183. UAE PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
  • Figure 189. South Africa PCR Technologies Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa PCR Technologies Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX10842

Global PCR technologies market size was valued at USD 15.05 billion in 2023, and is expected to reach USD 29.75 billion in 2031, with a CAGR of 8.89% for the forecast period between 2024 and 2031F. The Polymerase Chain Reaction technologies market is a rapidly growing field in molecular biology, life sciences, and biotechnology. The PCR technologies market is expanding owing to the increasing application of PCR in clinical disease diagnosis and genetic and molecular testing. The prevalence of infectious diseases like hepatitis, influenza, HIV infection, and COVID-19 infection which require PCR techniques for diagnosis, have been on the rise in recent years, driving demand in the global PCR technologies market.

Advancements in PCR techniques, such as digital PCR (dPCR) and real-time PCR (qPCR), offer benefits like low reagent consumption, automation of workflow, and greater reproducibility and precision, which are encouraging the adoption of PCR technologies, further fueling the market growth. Growing market penetration in emerging countries and attractive opportunities in the PCR technologies market have led to increased funding and investments. With increasing interest from investors and market players, the demand and supply both are significantly increasing. Additionally, government support for research and development is further encouraging market development. However, the high cost of PCR instruments, technical limitations of PCR technology, and lack of skilled professionals to perform the protocols are major restraints for the global PCR technologies market.

In November 2023, QIAGEN announced the launch of three new kits (QIAcuity Mycoplasma Quant Kit, QIAcuity OneStep Advanced EG Kit, and QIAcuity Mericon Food Testing Kits) for using them with its QIAcuity systems. The launch has a part where major new software updates are designed to expand the portfolio of applications for the use of dPCR technology in areas like cell and gene therapies, quantification of DNA and RNA, as well as food and pharmaceutical safety.

Increasing Prevalence of Infectious and Genetic Diseases

The increasing prevalence of infectious diseases like hepatitis, influenza, HIV is a significant driver for the PCR technologies market. The rise in infectious diseases and genetic diseases has led to a growing demand for PCR technologies, as they play a crucial role in the diagnosis and monitoring of these diseases. PCR is widely used in the detection of various infectious agents, including viruses, bacteria, and fungi, making it an indispensable tool in infectious disease management. PCR technologies are also used in the detection of genetic abnormalities causing genetic diseases, further fueling the market for growth.

According to WHO, about 39.0 million people were living with HIV at the end of 2022, including about 1.5 million children within the age group of 0 to 14 years. Seasonal influenza throughout the winter can infect up to 20% of the population and result in significant death. According to WHO data, respiratory illnesses associated with seasonal influenza causes up to 650,000 deaths globally each year.

Expanding Applications in Clinical Diagnosis and Genetic and Molecular Testing

PCR technology has several practical applications in the field of clinical diagnosis and in recent years, with increasing research and development, a significant expansion of PCR applications has been observed. PCR technology has been extensively utilized for COVID-19 diagnosis, driving demand in the market. Several notable applications of PCR technologies include broad-spectrum pathogen detection, assessment and surveillance of emerging infections, early detection of biological threat agents, and antimicrobial resistance analysis. Market players are coming up with innovative products for emerging applications of PCR technologies. In August 2022, GenScript USA Inc. launched a monkeypox virus PCR test kit, which was developed in partnership with Anbio Biotechnology. The kit was developed to address the monkeypox public health emergency in the United States.

Reagents and Consumables Segments are Expected to Dominate the Market

Reagents and consumables segments are expected to grow at a fast rate in the forecasted period. The instruments used for PCR tests are one-time investments while the reagents and consumables are repeatedly consumed and purchased, which drives major revenue. Reagents like primers, polymerase, nucleotides, reaction buffers, and consumables like well plates and pipette tips are consumed completely in each PCR process and need to be refilled for the next test, drawing reoccurring revenue in the market.

North America is Expected to Lead the PCR Technologies Market

North America dominates the global PCR market, with the United States and Canada holding largest market shares. The region's dominance is attributed to several factors, including extensive research infrastructure and a well-established regulatory framework that expedites approvals for new therapies. The presence of major pharmaceutical and biotechnology companies in the region has driven the development and adoption of PCR technologies. Additionally, North America has attracted significant investments in PCR research and development, enabling the establishment of state-of-the-art facilities and access to advanced technologies.

Key Players Landscape and Outlook

The market landscape for PCR technologies is growing with several key players contributing to its development and commercialization. The key players in this market include Bio-Rad Laboratories Inc., Merck KGaA, QIAGEN and others. These companies are involved in various growth strategies, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions to enhance their presence.

In September 2023, Bio-Rad Laboratories, Inc. announced the launch of two new PCR instruments named PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are a novel addition to Bio-Rad Laboratories' portfolio of conventional PCR instruments. PTC Tempo 48/48 has the unique feature of two separate compartments with manual lids which allows two protocols to run simultaneously. The launch aims to support PCR applications in basic and translational research, process development, and quality control.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global PCR Technologies Market Outlook, 2017-2031F

  • 5.1 Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Instruments
    • 4.2.2. Reagents
    • 4.2.3. Consumables
    • 4.2.4. Software and Services
    • 4.2.5. Others
  • 4.3. By Technology
    • 4.3.1. Conventional PCR
    • 4.3.2. qPCR (Real-Time PCR)
    • 4.3.3. dPCR (Digital PCR)
    • 4.3.4. Other PCR Technologies
  • 4.4. By Application
    • 4.4.1. Research Applications
      • 4.4.1.1. Genotyping
      • 4.4.1.2. Sequencing
      • 4.4.1.3. Gene Expression
      • 4.4.1.4. Forensics
    • 4.4.2. Diagnostics Applications
    • 4.4.3. Others
  • 4.5. By End-user
    • 4.5.1. Hospital
    • 4.5.2. Diagnostic Centre
    • 4.5.3. Pharmaceutical and Biotechnology Companies
    • 4.5.4. Clinical Research Organizations
    • 4.5.5. Academia Laboratories
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East & Africa
  • 4.7. By Company Market Share (%), 2023

5. Global PCR Technologies Market Outlook, By Region, 2017-2031F

  • 5.1. North America
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Instruments
      • 5.1.2.2. Reagents
      • 5.1.2.3. Consumables
      • 5.1.2.4. Software and Services
      • 5.1.2.5. Others
    • 5.1.3. By Technology
      • 5.1.3.1. Conventional PCR
      • 5.1.3.2. qPCR (Real-Time PCR)
      • 5.1.3.3. dPCR (Digital PCR)
      • 5.1.3.4. Other PCR Technologies
    • 5.1.4. By Application
      • 5.1.4.1. Research Applications
      • 5.1.4.1.1. Genotyping
      • 5.1.4.1.2. Sequencing
      • 5.1.4.1.3. Gene Expression
      • 5.1.4.1.4. Forensics
      • 5.1.4.2. Diagnostics Applications
      • 5.1.4.3. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospital
      • 5.1.5.2. Diagnostic Centre
      • 5.1.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.5.4. Clinical Research Organizations
      • 5.1.5.5. Academia Laboratories
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.2. Reagents
      • 5.1.6.2.3. Consumables
      • 5.1.6.2.4. Software and Services
      • 5.1.6.2.5. Others
      • 5.1.6.3. By Technology
      • 5.1.6.3.1. Conventional PCR
      • 5.1.6.3.2. qPCR (Real-Time PCR)
      • 5.1.6.3.3. dPCR (Digital PCR)
      • 5.1.6.3.4. Other PCR Technologies
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Research Applications
      • 5.1.6.4.1.1. Genotyping
      • 5.1.6.4.1.2. Sequencing
      • 5.1.6.4.1.3. Gene Expression
      • 5.1.6.4.1.4. Forensics
      • 5.1.6.4.2. Diagnostics Applications
      • 5.1.6.4.3. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospital
      • 5.1.6.5.2. Diagnostic Centre
      • 5.1.6.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.4. Clinical Research Organizations
      • 5.1.6.5.5. Academia Laboratories
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Therapy
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Agilent Technologies Inc.
  • 13.3. Becton, Dickinson and Company
  • 13.4. bioMerieux SA
  • 13.5. Bio-Rad Laboratories Inc.
  • 13.6. Merck KGaA
  • 13.7. PerkinElmer Inc.
  • 13.8. Promega Corporation
  • 13.9. Siemens Healthcare
  • 13.10. Thermo Fisher Scientific Inc.
  • 13.11. Danaher Corporation
  • 13.12. QIAGEN
  • 13.13. QuantuMDx Group Ltd
  • 13.14. Eppendorf

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer